Drug Shortage Report for ACT RANITIDINE
Report ID | 104307 |
Drug Identification Number | 02248570 |
Brand name | ACT RANITIDINE |
Common or Proper name | RANITIDINE 150MG TABLETS |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-01-22 |
Estimated end date | |
Actual end date | 2020-05-08 |
Shortage status | Resolved |
Updated date | 2020-05-14 |
Company comments | This item is discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-01-24 | English | Compare |
v2 | 2020-01-24 | French | Compare |
v3 | 2020-05-14 | English | Compare |
v4 | 2020-05-14 | French | Compare |
Showing 1 to 4 of 4